|
|
|
|
Vol. 302, Issue 1, 225-231, July 2002
Faculty of Pharmaceutical Sciences, Toyama Medical and
Pharmaceutical University, Toyama (K.-i.H., M.T.); Core Research for
Evolutional Science and Technology of Japan Science and Technology
Corporation, Kawaguchi (K.-i.H., M.T., S.O., H.T., T.Te.); Department
of Molecular Biopharmacy and Genetics, Graduate School of
Pharmaceutical Sciences, and New Industry Creation Hatchery Center
(S.O., H.T., T.Te.), Tohoku University, Sendai (S.O., H.T., S.S.,
T.Te.); Department of Pharmacology and Toxicology, Kyorin University
School of Medicine, Tokyo (Y.K., H.E.); and Institute of Molecular and
Cellular Biosciences, University of Tokyo, Tokyo, (M.N., T.Ts.) Japan
The purpose of the present study was to elucidate the mechanism
of enhancement of L-cystine uptake at the blood-brain
barrier (BBB). The uptake of [14C]L-cystine
and [3H]L-glutamic acid (L-Glu)
was determined using a mouse brain endothelial cell line (MBEC4) as an
in vitro BBB model. The mRNA levels of L-cystine/L-Glu exchanger, system
xc
, which consists of xCT and 4F2hc, were
determined by quantitative real-time reverse transcription-polymerase
chain reaction analysis. The
[14C]L-cystine uptake by MBEC4 cells appeared
to be mediated via an Na+-independent saturable process.
The corresponding Michaelis-Menten constant
(Km) was 63.7 µM. In the presence of
L-Glu, there was competitive inhibition with an inhibition
constant (Ki) of 83.5 µM.
[3H]L-Glu uptake in the absence of
Na+ was saturable with a Km of
48.1 µM, and it exhibited competitive inhibition with a
Ki of 24.9 µM in the presence of
L-cystine. The mutual inhibition between
L-cystine and L-Glu and the type of inhibition
suggest that system xc
operates in MBEC4
cells. The xCT and 4F2hc mRNAs were expressed in MBEC4 cells and,
following diethyl maleate (DEM) treatment, the xCT mRNA level and
L-cystine uptake in MBEC4 cells were enhanced in parallel
with an increase in DEM concentration (up to 500 µM). Concomitantly,
the glutathione concentration in MBEC4 cells was increased. In
conclusion, system xc
-mediated
L-cystine uptake takes place in MBEC4 cells.
L-Cystine transport via system xc
at the BBB is likely to be induced under oxidative stress conditions following DEM treatment due to enhanced transcription of the xCT gene.
This article has been cited by other articles:
![]() |
S. Numazawa, H. Sakaguchi, R. Aoki, T. Taira, and T. Yoshida Regulation of the susceptibility to oxidative stress by cysteine availability in pancreatic {beta}-cells Am J Physiol Cell Physiol, August 1, 2008; 295(2): C468 - C474. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Featherstone and S. A. Shippy Regulation of Synaptic Transmission by Ambient Extracellular Glutamate Neuroscientist, April 1, 2008; 14(2): 171 - 181. [Abstract] [PDF] |
||||
![]() |
H. Augustin, Y. Grosjean, K. Chen, Q. Sheng, and D. E. Featherstone Nonvesicular Release of Glutamate by Glial xCT Transporters Suppresses Glutamate Receptor Clustering In Vivo J. Neurosci., January 3, 2007; 27(1): 111 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Burdo, R. Dargusch, and D. Schubert Distribution of the Cystine/Glutamate Antiporter System xc- in the Brain, Kidney, and Duodenum J. Histochem. Cytochem., May 1, 2006; 54(5): 549 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Bridges, H. Hu, S. Miyauchi, U. N. Siddaramappa, M. E. Ganapathy, L. Ignatowicz, D. M. Maddox, S. B. Smith, and V. Ganapathy Induction of Cystine-Glutamate Transporter xc- by Human Immunodeficiency Virus Type 1 Transactivator Protein Tat in Retinal Pigment Epithelium Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2906 - 2914. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Gukasyan, R. Kannan, V. H. L. Lee, and K.-J. Kim Regulation of L-Cystine Transport and Intracellular GSH Level by a Nitric Oxide Donor in Primary Cultured Rabbit Conjunctival Epithelial Cell Layers Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1202 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Mann, D. L. Yudilevich, and L. Sobrevia Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells Physiol Rev, January 1, 2003; 83(1): 183 - 252. [Abstract] [Full Text] [PDF] |
||||